Tubulin polymerization-IN-37

Modify Date: 2024-04-02 17:07:47

Tubulin polymerization-IN-37 Structure
Tubulin polymerization-IN-37 structure
Common Name Tubulin polymerization-IN-37
CAS Number 2011784-92-0 Molecular Weight 340.37
Density N/A Boiling Point N/A
Molecular Formula C19H20N2O4 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Tubulin polymerization-IN-37


Tubulin polymerization-IN-37 is a tubulin polymerization inhibitor (IC50: 2.3 μΜ). Tubulin polymerization-IN-37 binds to the colchicine site of tubulin and inhibits colchicine binding. Tubulin polymerization-IN-37 can be used in the research of cancers, such as lymphomas[1].

 Names

Name Tubulin polymerization-IN-37

 Tubulin polymerization-IN-37 Biological Activity

Description Tubulin polymerization-IN-37 is a tubulin polymerization inhibitor (IC50: 2.3 μΜ). Tubulin polymerization-IN-37 binds to the colchicine site of tubulin and inhibits colchicine binding. Tubulin polymerization-IN-37 can be used in the research of cancers, such as lymphomas[1].
Related Catalog
Target

Tubulin polymerization[1]

In Vitro Tubulin polymerization-IN-37 (compound 2f, 1 μΜ, 72 h) inhibits proliferation of lymphoma cells below 50%[1]. Tubulin polymerization-IN-37 (50 and 500 nM, 24-72 h) induces cell apoptosis and arrests cell in G2/M phase in VL51 and MINO cells[1]. Tubulin polymerization-IN-37 (5 μΜ) inhibits colchicine binding to tubulin by 80%[1]. Tubulin polymerization-IN-37 shows cytotoxicity against MCF-7 cells (IC50: 0.21 μΜ)[1]. Cell Proliferation Assay[1] Cell Line: VL51, MINO, HBL1, SU-DHL-10 cells. Concentration: 0-10 μΜ Incubation Time: 72 h Result: Inhibited cell proliferation to 28.1%, 8.6%, 7.3%, 13.8% at 1 μΜ, respectively.IC50s: 0.12, 0.07, 0.08, 0.07 μΜ, respectively. Cell Cycle Analysis[1] Cell Line: VL51 and MINO cells Concentration: 50 and 500 nM Incubation Time: 24, 48 and 72 h Result: Arrested cell in G2/M phase.
References

[1]. Michael D Wendt, et al. Development of [1,2]oxazoloisoindoles tubulin polymerization inhibitors: Further chemical modifications and potential therapeutic effects against lymphomas. J Med Chem. 2006 Feb; 49(3): 1165-81.

 Chemical & Physical Properties

Molecular Formula C19H20N2O4
Molecular Weight 340.37